NCT00636363

Brief Summary

To the safety and efficacy of a Bausch \& Lomb Multipurpose Solution when compared to Ciba vision Aquify Multipurpose solution

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
541

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 14, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

April 8, 2011

Completed
Last Updated

March 24, 2015

Status Verified

March 1, 2015

Enrollment Period

5 months

First QC Date

March 7, 2008

Results QC Date

February 3, 2011

Last Update Submit

March 4, 2015

Conditions

Outcome Measures

Primary Outcomes (3)

  • Slit-lamp Findings > Grade 2

    eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.

    Over 4 visits for 3 month period

  • Subjective Responses to Comfort Related Symptoms/Complaints

    Subject symptoms/complaints will be assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.

    Over 4 visits for the 3 month period

  • Contact Lens Deposits

    Lens deposits assessed at each follow-up visit. Degree of deposits assessed as none, light, medium, or heavy.

    At each visit for 3 months

Study Arms (3)

Multipurpose Solution - Rub Care

EXPERIMENTAL

Bausch \& Lomb Multipurpose Solution for use with contact lens care

Device: Bausch & Lomb Multipurpose Solution - Rub Care

Multipurpose Solution - No Rub Care

EXPERIMENTAL

Bausch \& Lomb Multipurpose Solution for use with contact lens care

Device: Bausch & Lomb Multipurpose Solution - No Rub Care

Ciba Vision Aquify Multipurpose Solution

ACTIVE COMPARATOR

Ciba Vision Aquify Multipurpose Solution for use with contact lens care

Device: Ciba Vision Aquify Multipurpose Solution

Interventions

Daily care for contact lenses - rub care regimen

Multipurpose Solution - Rub Care

Daily care for contact lenses - no rub care regimen

Multipurpose Solution - No Rub Care

daily care for contact lenses

Ciba Vision Aquify Multipurpose Solution

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subject is a habitual wearer of a silicone hydrogel or group IV contact lens
  • VA correctable to 0.3 LogMar or better (driving vision)
  • Clear central cornea
  • Subject uses a lens care system on a regular basis

You may not qualify if:

  • Systemic disease affecting ocular health
  • Using systemic or topical medications
  • wear monovision, multifocal or toric contact lenses
  • Any grade 2 or greater slit lamp findings

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Place Eye Care

Le Roy, New York, 14482, United States

Location

Results Point of Contact

Title
Robert Steffen
Organization
Bausch & Lomb

Study Officials

  • Mohinder Merchea, OD, PhD

    Bausch & Lomb Incorporated

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2008

First Posted

March 14, 2008

Study Start

March 1, 2008

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

March 24, 2015

Results First Posted

April 8, 2011

Record last verified: 2015-03

Locations